Published in Cardiovascular Business Week, December 29th, 2009
Concert also announced the addition of Lee Brettman, M.D. and Dennis Giesing, Ph.D., to its Product Advisory Board (PAB). They will provide Concert's PAB further expertise in the areas of clinical development and pharmacology. The PAB was established at Concert's inception to provide a source of deep industry...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.